You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resectable pancreatic adenocarcinoma

Showing 1 - 25 of 7,134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022

Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

Enrolling by invitation
  • Resectable Pancreatic Adenocarcinoma
    • Milan, Italy
      National Cancer Institute of Milan
    Mar 3, 2023

    Surgery After Neoadjuvant Chemotherapy in Locally Advanced

    Completed
    • Postoperative Complications
    • surgery after neoadjuvant chemotherapy
    • Seoul, Korea, Republic of
      Asan medical center
    Jun 1, 2023

    Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Sep 16, 2022

    Chemo Effect, Pancreas Cancer Trial in Barcelona (Neoadyuvant therapy)

    Not yet recruiting
    • Chemotherapy Effect
    • Pancreas Cancer
    • Neoadyuvant therapy
    • Barcelona, Spain
      Hospital del Mar
    Aug 23, 2022

    Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

    Active, not recruiting
    • Pancreatic Cancer
    • +2 more
    • Nab-paclitaxel and gemcitabine for R-PDAC Patients
    • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
    • Scottsdale, Arizona
    • +3 more
    Mar 8, 2022

    Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

    Suspended
    • Borderline Resectable Pancreatic Cancer
    • Intraoperative radiotherapy
    • Verona, Italy
      General and Pancreatic Surgery Unit, Pancreas Institute, Univers
    Nov 1, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +5 more
    • Durvalumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 12, 2022

    Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Hamilton, Ontario, Canada
      Juravinski Hospital
    Aug 5, 2022

    Identify microRNAs in Cachexia in Pancreatic Carcinoma

    Recruiting
    • Resectable Pancreatic Adenocarcinoma
    • Pancreatic cancer microRNA and messenger RNA expression.
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Jan 9, 2023

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal

    Recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • +3 more
    • Hafnium Oxide-containing Nanoparticles NBTXR3
    • Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • Leucovorin Calcium
    • +4 more
    • 's-Hertogenbosch, Netherlands
    • +19 more
    Jan 6, 2023

    Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

    Recruiting
    • Untreated Resectable Pancreatic Adenocarcinoma
    • +2 more
    • Paclitaxel protein bound
    • +3 more
    • Scottsdale, Arizona
      HonorHealth Research Institute
    May 10, 2022

    Survival, Quality of Life and Resectability in Locally Advanced

    Recruiting
    • Pancreas Cancer
    • +8 more
      • Umeå, Sweden
        Surgical Clinic at Umeå University Hospital
      Nov 23, 2022

      Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Loma Linda (Gemcitabine 1000 mg, nab-paclitaxel, Stereotactic

      Recruiting
      • Pancreas Adenocarcinoma
      • Resectable Pancreatic Cancer
      • Gemcitabine 1000 mg
      • +2 more
      • Loma Linda, California
        Loma Linda University Health
      Jun 14, 2022

      Systemic Immuno-inflammatory Factors in Resectable Pancreatic

      Completed
      • Pancreas Cancer, Duct Cell Adenocarcinoma
      • Systemic immune-inflammatory markers
      • Cluj-Napoca, Cluj, Romania
        Regional Institute of Gastroenterology and Hepatology "Prof. Dr.
      Nov 30, 2021

      Resectable Pancreatic Adenocarcinoma Trial in Seoul (neoadjuvant modified FOLFIRINOX)

      Recruiting
      • Resectable Pancreatic Adenocarcinoma
      • neoadjuvant modified FOLFIRINOX
      • Seoul, Korea, Republic of
        Division of Medical Oncology, Yonsei Cancer Center, Yonsei Univ.
      Sep 23, 2021

      Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Sep 22, 2023

      Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

      Completed
      • Pancreas Cancer
        • (no location specified)
        Jul 15, 2023

        Pancreatic Adenocarcinoma Trial in Evanston (5 Fluorouracil, Leucovorin, Irinotecan)

        Completed
        Has Results
        • Pancreatic Adenocarcinoma
        • 5 Fluorouracil
        • +3 more
        • Evanston, Illinois
          NorthShore University HealthSystem
        Nov 4, 2021

        Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

        Recruiting
        • Metastatic Pancreatic Ductal Adenocarcinoma
        • +12 more
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Nov 30, 2022

        Pancreas Cancer Trial in New York (Bethanechol, Gemcitabine, nab-paclitaxel)

        Recruiting
        • Pancreas Cancer
        • New York, New York
          Columbia University Medical Center
        Feb 3, 2022